Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

CAR T cells target senescent cells, improve healthspan in mice

Chimeric antigen receptor (CAR) T cells have transformed the treatment of blood cancers in recent years. And there have been positive signs the "living drugs" can be harnessed against other diseases, like autoimmune disorders.

2 Feb 2024

Engrailed-1 protein promotes pancreatic cancer progression and metastasis

Pancreatic cancer is the No. 3 cause of cancer-related deaths in the United States, and only 12% of patients survive five years after being diagnosed.

2 Feb 2024

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

Researchers at the University of Auckland are running a trial of castor oil as a potential safe and natural treatment for dry-eye disease following a successful pilot study.

2 Feb 2024

KFF Health News' 'What the Health?': The struggle over who gets the last word

The Supreme Court in March will hear oral arguments in two very different cases that boil down to the same question: How much power do "experts" in health and science deserve? At stake is the future accessibility of the abortion pill mifepristone, and the ability of government officials to advise social media companies about misinformation.

1 Feb 2024

CT scans may be better first step for evaluating chest pain

Previous studies have found less than 40% of patients with stable chest pain undergoing invasive coronary angiography are found to have obstructive coronary artery disease.

1 Feb 2024

CRISPR revolutionized: New method edits genes directly in the body

Most approved gene therapies today, including those involving CRISPR-Cas9, work their magic on cells removed from the body, after which the edited cells are returned to the patient.

1 Feb 2024

Circulatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illness

The association between biomarkers of cholesterol homeostasis and mortality in critically ill patients.

1 Feb 2024

Surge in syphilis cases leads some providers to ration penicillin

When Stephen Miller left his primary care practice to work in public health a little under two years ago, he said, he was shocked by how many cases of syphilis the clinic was treating.

1 Feb 2024

Gut microbiome may hold key to fighting common respiratory viruses

The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

30 Jan 2024

Singing mice unlock secrets behind how the brain bends time

Life has a challenging tempo. Sometimes, it moves faster or slower than we'd like. Nevertheless, we adapt. We pick up the rhythm of conversations. We keep pace with the crowd walking a city sidewalk.

30 Jan 2024

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

30 Jan 2024

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

There are many lingering mysteries from the COVID-19 pandemic. For instance, why does SARS-CoV-2, the virus behind the disease, cause severe symptoms in some patients, while many other coronaviruses don't? And what causes strange symptoms to persist even after the infection has been cleared from a person's system?

30 Jan 2024

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due to RSV infections.

30 Jan 2024

Researchers develop a more trustworthy method to diagnose diseases using AI tools

An interdisciplinary team of researchers at the University of Waterloo has developed a more trustworthy method to diagnose diseases such as COVID-19, pneumonia, and melanoma using artificial intelligence (AI) tools.

30 Jan 2024

How does the nasal cavity's immune system combat SARS-CoV-2?

Researchers discovered that CD4+ and CD8+ T cells play a crucial role in clearing COVID-19 infection in the nasal cavity but have limited impact on lung infections, with implications for understanding and treating the virus.

28 Jan 2024

Gene activity plays key role in immune cell production, study shows

As people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-19.

27 Jan 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection.

27 Jan 2024

Study offers insights into who's at risk for long COVID among immunocompromised patients

Early in the pandemic, clinicians noticed that certain immunocompromised patients were experiencing persistent SARS-CoV-2 infections, some lasting weeks to months at a time.

26 Jan 2024

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

How type 2 diabetes and genetic susceptibility to the disease impacted the severity of and mortality risk associated with coronavirus disease 2019.

26 Jan 2024

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine's (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

25 Jan 2024

Previous
1
...
48
49
50
51
52
53
54
...
1183
Next

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

CAR T cells target senescent cells, improve healthspan in mice

Engrailed-1 protein promotes pancreatic cancer progression and metastasis

New trial explores cold-pressed castor oil as safe, natural treatment for dry-eye disease

KFF Health News' 'What the Health?': The struggle over who gets the last word

CT scans may be better first step for evaluating chest pain

CRISPR revolutionized: New method edits genes directly in the body

Circulatory cholesterol levels are inversely linked to mortality of patients with sepsis and critical illness

Surge in syphilis cases leads some providers to ration penicillin

Gut microbiome may hold key to fighting common respiratory viruses

Singing mice unlock secrets behind how the brain bends time

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

"Zombie" viral fragments trigger inflammation to cause serious COVID-19 outcomes

Impact of nirsevimab immunization on pediatric RSV-related hospitalizations in Luxembourg

Researchers develop a more trustworthy method to diagnose diseases using AI tools

How does the nasal cavity's immune system combat SARS-CoV-2?

Gene activity plays key role in immune cell production, study shows

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Study offers insights into who's at risk for long COVID among immunocompromised patients

UK Biobank research reveals significant impact of type 2 diabetes on COVID-19 outcomes

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in